• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

联苯苄唑/尿素软膏治疗甲癣过程中的超微结构变化

Ultrastructural changes in onychomycosis during the treatment with bifonazole/urea ointment.

作者信息

Fritsch H, Stettendorf S, Hegemann L

机构信息

Institute of Anatomy, University of Lübeck, FRG.

出版信息

Dermatology. 1992;185(1):32-6. doi: 10.1159/000247399.

DOI:10.1159/000247399
PMID:1386263
Abstract

In the present study, we investigated the effects of bifonazole/urea ointment, a novel topical drug for the treatment of onychomycosis, on the ultrastructure of normal and fungus-infected human toenails by scanning electron microscopy. Nails were treated with the drug ex vivo and compared to untreated controls. During treatment, the corneocyte layers disintegrated, and the structure markedly loosened. After 5 days of treatment, the morphology of fungal cells, found at the undersurface of infected nails, was changed due to the antifungal drug action. The present data demonstrate that by the use of this drug, the agent effectively penetrates the nail plate and affects the fungal cells.

摘要

在本研究中,我们通过扫描电子显微镜研究了联苯苄唑/尿素软膏(一种用于治疗甲癣的新型局部用药)对正常和真菌感染的人趾甲超微结构的影响。趾甲在体外接受该药物治疗,并与未治疗的对照进行比较。治疗期间,角质形成细胞层解体,结构明显疏松。治疗5天后,在感染趾甲下表面发现的真菌细胞形态因抗真菌药物作用而改变。目前的数据表明,通过使用这种药物,该制剂可有效穿透甲板并影响真菌细胞。

相似文献

1
Ultrastructural changes in onychomycosis during the treatment with bifonazole/urea ointment.联苯苄唑/尿素软膏治疗甲癣过程中的超微结构变化
Dermatology. 1992;185(1):32-6. doi: 10.1159/000247399.
2
Efficacy, safety and tolerability of an optimized avulsion technique with onyster® (40% urea ointment with plastic dressing) ointment compared to bifonazole-urea ointment for removal of the clinically infected nail in toenail onychomycosis: a randomized evaluator-blinded controlled study.一项优化的撕脱技术(40%尿素软膏加塑料敷料)与联苯苄唑-尿素软膏治疗临床感染性趾甲甲真菌病的疗效、安全性和耐受性的比较:一项随机、评估者盲法对照研究。
Dermatology. 2013;226(1):5-12. doi: 10.1159/000345105. Epub 2013 Mar 1.
3
Onychomycosis in children: treatment with bifonazole-urea.儿童甲癣:联苯苄唑脲治疗
Pediatr Dermatol. 2000 Jul-Aug;17(4):310-4. doi: 10.1046/j.1525-1470.2000.01761.x.
4
Treatment of onychomycosis with a bifonazole-urea combination.联苯苄唑-尿素组合治疗甲癣
Mycoses. 1990 Apr;33(4):167-71. doi: 10.1111/myc.1990.33.4.167.
5
Non-traumatic topical treatment of onychomycosis with urea associated with bifonazole.尿素联合联苯苄唑对甲癣进行非创伤性局部治疗
Mycoses. 1991 Nov-Dec;34(11-12):499-504. doi: 10.1111/j.1439-0507.1991.tb00867.x.
6
[Treatment of onychomycosis using 40% urea with 1% bifonazole].
Harefuah. 1992 Feb 2;122(3):159-60.
7
Non-traumatic removal of the nail and simultaneous treatment of onychomycosis.非创伤性拔甲及同时治疗甲癣
Dermatologica. 1984;169 Suppl 1:117-20. doi: 10.1159/000249650.
8
The topical treatment of onychomycosis using a new combined urea/imidazole preparation.使用新型尿素/咪唑复方制剂局部治疗甲癣。
Clin Exp Dermatol. 1988 May;13(3):164-7. doi: 10.1111/j.1365-2230.1988.tb01961.x.
9
Microstructural alterations in the onychomycotic and psoriatic nail: Relevance in drug delivery.甲真菌病和银屑病指甲的微观结构改变:在药物输送中的相关性。
Eur J Pharm Biopharm. 2018 Jul;128:48-56. doi: 10.1016/j.ejpb.2018.04.012. Epub 2018 Apr 17.
10
Efficacy of 4 weeks topical bifonazole treatment for onychomycosis after nail ablation with 40% urea: a double-blind, randomized, placebo-controlled multicenter study.40%尿素甲剥离术后 4 周局部联苯苄唑治疗甲真菌病的疗效:一项双盲、随机、安慰剂对照多中心研究。
Mycoses. 2013 Jul;56(4):414-21. doi: 10.1111/myc.12037. Epub 2013 Apr 16.

引用本文的文献

1
The use of urea for the treatment of onychomycosis: a systematic review.尿素治疗甲真菌病的应用:系统评价。
J Foot Ankle Res. 2019 Apr 11;12:22. doi: 10.1186/s13047-019-0332-3. eCollection 2019.
2
A method to measure the amount of drug penetrated across the nail plate.一种测量穿透甲板的药物量的方法。
Pharm Res. 2001 Oct;18(10):1468-71. doi: 10.1023/a:1012265125158.